Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eswatini
Eswatini: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 90.0% in 2025. ◆ Volatile
Latest (2025)
90.0%
Change on year
up 15.4%
World rank
70th
of 194 countries
All-time high
96.0%
in 2022
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eswatini, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, pneumococcal conjugate second or third-dose vaccines (pcvc) in Eswatini stood at 90.0%.
The figure is up 15.4% on the previous year and unchanged over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Eswatini peaked at 96.0% in 2022 and was at its lowest, 0.0%, in 2008.
Eswatini ranks 70th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Eswatini, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 67.0% | — |
| 2015 | 90.0% | +34.3% |
| 2016 | 90.0% | +0.0% |
| 2017 | 87.0% | -3.3% |
| 2018 | 88.0% | +1.1% |
| 2019 | 87.0% | -1.1% |
| 2020 | 83.0% | -4.6% |
| 2021 | 63.0% | -24.1% |
| 2022 | 96.0% | +52.4% |
| 2023 | 66.0% | -31.2% |
| 2024 | 78.0% | +18.2% |
| 2025 | 90.0% | +15.4% |
Eswatini compared with similar countries
- Eswatini's 90.0% is above the median for lower middle income countries, which is 84.0%, 1.1× the median. (47 countries reporting)
- Eswatini's 90.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 50.9% | 0.0% | 90.0% | 10 |
| 2020s | 79.3% | 63.0% | 96.0% | 6 |
Countries ranked near Eswatini
More health data for Eswatini
- Un projection of annual infant deaths, annual growth rate -1.9 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6228 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,406 deaths per 1,000 people (2090)
- Number of infants who die before age 1 206 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.6874 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0553 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5455 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Eswatini?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Eswatini was 90.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eswatini?
- The highest recorded value was 96.0% in 2022.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Eswatini?
- The lowest recorded value was 0.0% in 2008.
- How does Eswatini rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Eswatini ranks 70th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Eswatini?
- Over the last ten years it is unchanged. The long-run trend across the full record is volatile.
- Where does this Eswatini data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).